In April, Texas-based U.S. District Judge Matthew Kacsmaryk imposed a nationwide ban on mifepristone. The Supreme Court put a hold on the decision until the justices could hear the case this term, keeping the abortion pill widely available for the time being. 

This case could not only affect access to mifepristone, but also the FDA's authority to regulate medications. 

Should the Supreme Court block the abortion pill nationwide?